Correction to: Effcacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study.

Adv Ther

Department of Dermatology, School of Medicine, Rui Jin Hospital, Shanghai Jiao Tong University, 197, Rui Jin Er Road, Shanghai, 200025, China.

Published: November 2024

Download full-text PDF	Source
http://dx.doi.org/10.1007/s12325-024-03059-6	DOI Listing

Publication Analysis

correction effcacy

effcacy ixekizumab

ixekizumab chinese

chinese patients

patients moderate-to-severe

moderate-to-severe psoriasis

psoriasis special

special body

body area

area involvement

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!